Spring 2027 Integrated Pharmacology Co-op: In Vivo Research

MFS Investments; Boston (MA); Hybrid; USD 34,000 - 69,000; Full time

Benefits offered by this job

Free 24/7 onsite gym access

Free meals—daily

Subsidized commuter benefits

Career development opportunities

Company social events

Job summary

Vertex Pharmaceuticals in Boston is seeking a Spring 2027 Integrated Pharmacology Co-op. You will join a collaborative team to support in vivo and ex vivo pharmacology studies, contributing to late-stage drug discovery.

The program runs January to June 2027 and offers robust mentorship, real-world projects, and professional growth opportunities. The role requires enrollment in an advanced degree, hands-on experience with mouse dosing and molecular assays, and strong communication skills.

Qualifications

• Enrollment in an advanced degree program, Jan–Jun 2027.
• Hands-on experience with in vivo mouse dosing routes (SC/IV/PO/IP).
• Strong written and verbal communication; collaborative team player.

Responsibilities

• Support design, execution, and analysis of in vivo and ex vivo pharmacology studies.
• Prepare summaries, figures, and presentations for project teams.
• Maintain accurate lab records and communicate results in group meetings.
• Collaborate with cross-functional colleagues on study timelines and priorities.

Skills

In vivo mouse techniques

Flow cytometry

qPCR

Protein assays

Education

Undergraduate or graduate degree in pharmacology or biological sciences

Tools

Western blotting

ELISA

Job description

Vertex Pharmaceuticals in Boston is seeking a Spring 2027 Integrated Pharmacology Co-op. You will join a collaborative team to support in vivo and ex vivo pharmacology studies, contributing to late-stage drug discovery.

The program runs January to June 2027 and offers robust mentorship, real-world projects, and professional growth opportunities. The role requires enrollment in an advanced degree, hands-on experience with mouse dosing and molecular assays, and strong communication skills.